Filtered By:
Source: Radcliffe Cardiology
Condition: Atrial Fibrillation
Therapy: Gene Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
The Use of Gene Therapy for Ablation of Atrial Fibrillation
In the United States, atrial fibrillation (AF) is the most common sustained cardiac arrhythmia affecting approximately six million patients and contributing to a greatly increased risk of stroke, heart failure (HF) and overall morbidity and mortality.1,2 The prevalence of AF is increasing as the average age of the population increases.3,4
Source: Radcliffe Cardiology - November 25, 2014 Category: Cardiology Authors: lravichander Source Type: research
